Sterling Capital Management LLC Day One Biopharmaceuticals, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 65 shares of DAWN stock, worth $965. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65Holding current value
$965% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
175Shares Held
83.4MCall Options Held
114KPut Options Held
167K-
Ra Capital Management, L.P. Boston, MA7.87MShares$117 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$95.5 Million11.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$87.4 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$72.4 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$67.3 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.09B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...